サマリー

中東・アフリカの人工呼吸器市場は、2023年の7億6,833万米ドルから2031年には13億1,204万米ドルに達し、2024年から2031年の予測期間中に年平均成長率7.1％で成長すると予測される。
市場区分
中東・アフリカの人工呼吸器市場：製品タイプ別（集中治療用人工呼吸器、ポータブル人工呼吸器、新生児用人工呼吸器）、モダリティ別（侵襲的人工呼吸、非侵襲的人工呼吸）、タイプ別（成人用人工呼吸器、新生児用人工呼吸器、小児用人工呼吸器）、モード別（複合モード人工呼吸、ボリュームモード人工呼吸器、プレッシャーモード人工呼吸器、その他)、エンドユーザー(病院、専門クリニック、在宅ケア、長期ケアセンター、リハビリセンター)、国別(南アフリカ、その他の中東・アフリカ地域) - 2031年までの産業動向と予測

中東およびアフリカの人工呼吸器市場動向の概要

促進要因
- 慢性呼吸器疾患の有病率の増加
- 呼吸器疾患を患いやすい老人人口の増加
抑制要因

- 人工呼吸器使用に伴う副作用
機会

- 医療費の増加
市場プレーヤー
中東・アフリカの人工呼吸器市場で事業を展開する主な市場プレーヤーは以下の通り：
- Koninklijke Philips N.V.
-GEヘルスケア
-VYAIRE社
-Drägerwerk AG & Co.KGaA
-ゲッティンゲAB
-メドトロニック
-エア・リキード
-シンセン・ミンドレイ・バイオメディカル・エレクトロニクス社
-スミス・グループ plc
-レスメッド
-ハミルトンメディカル
-フィッシャー＆ペイケル・ヘルスケア・リミテッド
-ゾール・メディカル・コーポレーション

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA VENTILATOR MARKET 13
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 15
2 MARKET SEGMENTATION 17
2.1 MARKETS COVERED 17
2.2 GEOGRAPHICAL SCOPE 18
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 MULTIVARIATE MODELLING 23
2.7 PRODUCT TYPE VENTILATOR LIFELINE CURVE 24
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.9 DBMR MARKET POSITION GRID 26
2.10 SECONDARY SOURCES 27
2.11 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 31
5 MARKET OVERVIEW 32
5.1 DRIVERS 34
5.1.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISEASES 34
5.1.2 INCREASING GERIATRIC POPULATION PRONE TO RESPIRATORY DISORDERS 35
5.1.3 INCREASING NUMBER OF ICU BED 35
5.1.4 TECHNOLOGICAL ADVANCEMENT IN THE VENTILATORS 36
5.2 RESTRAINTS 37
5.2.1 SIDE EFFECTS ASSOCIATED WITH THE USAGE OF VENTILATORS 37
5.2.2 HIGH COST OF VENTILATORS 38
5.3 OPPORTUNITIES 39
5.3.1 INCREASING HEALTHCARE EXPENDITURE 39
5.3.2 RISING NUMBER OF PREMATURE BIRTHS 41
5.3.3 INCREASING USAGE OF ICU EQUIPMENT 42
 
5.4 CHALLENGE 43
5.4.1 STRINGENT LEGAL FRAMEWORK 43
5.4.2 RISK ASSOCIATED WITH THE MECHANICAL VENTILATION 44
6 MIDDLE EAST AND AFRICA VENTILATOR MARKET, BY PRODUCT TYPE 46
6.1 OVERVIEW 47
6.2 INTENSIVE CARE VENTILATORS 50
6.2.1 HIGH-END ICU VENTILATORS 51
6.2.2 BASIC ICU VENTILATORS 51
6.2.3 MID-END ICU VENTILATORS 51
6.3 PORTABLE VENTILATORS 51
6.4 NEONATAL VENTILATORS 51
7 MIDDLE EAST AND AFRICA VENTILATOR MARKET, BY MODALITY 52
7.1 OVERVIEW 53
7.2 INVASIVE VENTILATION 56
7.3 NON-INVASIVE VENTILATION 56
7.3.1 VOLUME-CYCLED VENTILATORS 57
7.3.2 PRESSURE-CYCLED VENTILATORS 57
7.3.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS 57
7.3.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS 57
7.3.5 FLOW-CYCLED VENTILATORS 57
7.3.6 TIME-CYCLED VENTILATORS 57
8 MIDDLE EAST AND AFRICA VENTILATOR MARKET, BY VENTILATOR TYPE 58
8.1 OVERVIEW 59
8.2 ADULT VENTILATORS 62
8.3 NEONATAL VENTILATORS 62
8.4 PEDIATRIC VENTILATORS 63
9 MIDDLE EAST AND AFRICA VENTILATOR MARKET, BY MODE 64
9.1 OVERVIEW 65
9.2 COMBINED-MODE VENTILATION 68
9.3 VOLUME-MODE VENTILATION 68
9.4 PRESSURE-MODE VENTILATOR 69
9.5 OTHER 69
 
10 MIDDLE EAST AND AFRICA VENTILATOR MARKET, BY END USER 70
10.1 OVERVIEW 71
10.2 HOSPITALS 74
10.3 SPECIALTY CLINICS 74
10.4 HOMECARE SETTINGS 75
10.5 LONG TERM CARE CENTRES 75
10.6 REHABILITATION CENTRES 76
10.7 OTHERS 76
11 MIDDLE EAST AND AFRICA VENTILATOR MARKET, BY REGION 77
11.1 MIDDLE EAST AND AFRICA 79
11.1.1 SOUTH AFRICA 82
11.1.2 REST OF MIDDLE EAST AND AFRICA 85
12 MIDDLE EAST AND AFRICA VENTILATOR MARKET: COMPANY LANDSCAPE 86
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 86
13 SWOT ANALYSIS 87
14 COMPANY PROFILES 88
14.1 KONINKLIJKE PHILIPS N.V. 88
14.1.1 COMPANY SNAPSHOT 88
14.1.2 REVENUE ANALYSIS 88
14.1.3 COMPANY SHARE ANALYSIS 89
14.1.4 PRODUCT PORTFOLIO 89
14.1.5 RECENT DEVELOPMENT 91
14.2 GE HEALTHCARE 92
14.2.1 COMPANY SNAPSHOT 92
14.2.2 REVENUE ANALYSIS 92
14.2.3 COMPANY SHARE ANALYSIS 93
14.2.4 PRODUCT PORTFOLIO 93
14.2.5 RECENT DEVELOPMENT 93
14.3 VYAIRE 94
14.3.1 COMPANY SNAPSHOT 94
14.3.2 COMPANY SHARE ANALYSIS 94
14.3.3 PRODUCT PORTFOLIO 95
14.3.4 RECENT DEVELOPMENTS 98
 
14.4 DRÄGERWERK AG & CO. KGAA 99
14.4.1 COMPANY SNAPSHOT 99
14.4.2 REVENUE ANALYSIS 99
14.4.3 COMPANY SHARE ANALYSIS 100
14.4.4 PRODUCT PORTFOLIO 100
14.4.5 RECENT DEVELOPMENTS 103
14.5 GETINGE AB 104
14.5.1 COMPANY SNAPSHOT 104
14.5.2 REVENUE ANALYSIS 104
14.5.3 COMPANY SHARE ANALYSIS 105
14.5.4 PRODUCT PORTFOLIO 105
14.5.5 RECENT DEVELOPMENT 106
14.6 AIR LIQUIDE 107
14.6.1 COMPANY SNAPSHOT 107
14.6.2 REVENUE ANALYSIS 107
14.6.3 PRODUCT PORTFOLIO 108
14.6.4 RECENT DEVELOPMENT 109
14.7 FISHER & PAYKEL HEALTHCARE LIMITED 110
14.7.1 COMPANY SNAPSHOT 110
14.7.2 REVENUE ANALYSIS 110
14.7.3 PRODUCT PORTFOLIO 111
14.7.4 RECENT DEVELOPMENTS 111
14.8 HAMILTON MEDICAL 112
14.8.1 COMPANY SNAPSHOT 112
14.8.2 PRODUCT PORTFOLIO 112
14.8.3 RECENT DEVELOPMENTS 114
14.9 LEISTUNG EQUIPAMENTOS LTDA. 115
14.9.1 COMPANY SNAPSHOT 115
14.9.2 PRODUCT PORTFOLIO 115
14.9.3 RECENT DEVELOPMENT 115
14.10 MEDTRONIC 116
14.10.1 COMPANY SNAPSHOT 116
14.10.2 REVENUE ANALYSIS 116
14.10.3 PRODUCT PORTFOLIO 117
14.10.4 RECENT DEVELOPMENTS 118
14.11 PENLON LIMITED 119
14.11.1 COMPANY SNAPSHOT 119
14.11.2 PRODUCT PORTFOLIO 119
14.11.3 RECENT DEVELOPMENT 120
 
14.12 RESMED 121
14.12.1 COMPANY SNAPSHOT 121
14.12.2 REVENUE ANALYSIS 121
14.12.3 PRODUCT PORTFOLIO 122
14.12.4 RECENT DEVELOPMENTS 123
14.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 124
14.13.1 COMPANY SNAPSHOT 124
14.13.2 PRODUCT PORTFOLIO 124
14.13.3 RECENT DEVELOPMENT 126
14.14 SMITHS GROUP PLC 127
14.14.1 COMPANY SNAPSHOT 127
14.14.2 REVENUE ANALYSIS 127
14.14.3 PRODUCT PORTFOLIO 128
14.14.4 RECENT DEVELOPMENT 129
14.15 ZOLL MEDICAL CORPORATION 130
14.15.1 COMPANY SNAPSHOT 130
14.15.2 PRODUCT PORTFOLIO 130
14.15.3 RECENT DEVELOPMENT 131
15 QUESTIONNAIRE 132
16 RELATED REPORTS 135